Rebalix
Invesco · sheet of 4 September 2026
Invesco · sheet of 4 September 2026ETF sheet · official issuer and register data
Invesco Emerging Markets USD Bond UCITS ETF Dist
PEMD · IE00BF51K132 · class Dist · USD · domicile Ireland
Bonds · Government USD · Broad (all maturities) · Emerging marketsSFDR art. 6
Index tracked: Bloomberg Emerging Markets USD Sovereign Index
- TER
- 0.25%+ trans. 0.04%
- Fund size
- 60 m EUR
- Tracking difference
- −0.59%3-year avg
- 🇮🇹 tax rate
- 14.43%white list 85.74%
- Replication
- Physical
- Income
- Distributingquarterly
- Duration
- 6.53 yrsmedium (3–7 years)
Launch 16 Nov 2017 · costs from the KID as of 14 Aug 2026 · 420 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to achieve the total return performance of the Bloomberg Emerging Markets USD Sovereign Index (the "Index"), less fees, expenses and transaction costs. Investment approach: The Fund is a passively managed ETF. To achieve the investment objective, the Fund will employ sampling techniques to select securities in the Index which may include but are not limited to index weighted average duration, industry sectors, country weights, liquidity and credit quality. The use of the sampling approach will result in…
Performance since series start (in euro) — base 100
16 Nov 2017 → 1 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +6.2% |
| 3 years | +20.4% |
| 5 years | +11.4% |
| 10 years | series too young |
| Since series start | +27.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 4.91% | 5.59% | 6.68% |
| Max drawdown | −5.13% | −6.80% | −30.40% |
| Sharpe | -0.36 | -0.01 | -0.88 |
| Sortino | -0.48 | -0.01 | -1.13 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PEMD · IE00BF51K1321
RebalixPEMD · IE00BF51K132 · sheet of 4 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +12.77% | +13.10% | −0.34% |
| 2024 | +6.24% | +7.03% | −0.79% |
| 2023 | +10.31% | +10.96% | −0.65% |
| 2022 | −15.98% | −17.43% | +1.45% |
| 2021 | −2.77% | −2.32% | −0.44% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 58.0%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in USD
Frequency: quarterly · last 12 months: 0.9108 USD (5.55% of NAV) · last ex-date 10 Sept 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 0.6759 | — |
| 2025 | 4 | 0.9194 | +5.86% |
| 2024 | 4 | 0.9147 | +5.85% |
| 2023 | 4 | 0.8682 | +5.78% |
| 2022 | 4 | 0.7415 | +3.96% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 420 securities · top-10 weight = 6.8%
Countries (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
PEMD · Borsa Italiana (ETFplus)
EMSB · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 7 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BF51K132
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BF51K132
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · PEMD · IE00BF51K1322